Related Experiment Videos
Mistletoe extract-induced effects on immunocompetent cells: in vitro studies
Anti-Cancer Drugs
|April 1, 1997
Summary
This study shows a fermented mistletoe extract from pine trees has low cytotoxicity and stimulates immune cells like T helper cells and macrophages. This extract may modulate the immune system in healthy individuals and patients with colorectal tumors.
Area of Science:
- Immunology
- Phytochemistry
Background:
- Mistletoe extracts exhibit cytotoxic and immunomodulatory effects, influenced by host tree, processing, and composition.
- Fermented mistletoe extract from Viscum album L. on pine trees shows reduced cytotoxicity compared to other preparations.
- This specific extract has a very low content of mistletoe lectins.
Purpose of the Study:
- To investigate the immunomodulatory effects of a fermented mistletoe extract from pine trees.
- To analyze the impact of this extract on peripheral blood mononuclear cells (PBMC) from healthy, allergic, and colorectal tumor patients.
- To explore the involvement of immune cells and cytokine profiles in response to the mistletoe extract.
Main Methods:
- In vitro studies using fermented mistletoe extract from Viscum album L. grown on pine trees.
- Assessing cytotoxicity and immune cell stimulation of peripheral blood mononuclear cells (PBMC).
- Analyzing the involvement of CD4+ T helper cells, CD14+ monocytes/macrophages, and cytokine production (Type-1 and Type-2).
Main Results:
- The fermented mistletoe extract was less cytotoxic to PBMC compared to other preparations.
- The extract stimulated PBMC from healthy and allergic donors, with observed involvement of CD4+ T helper cells and CD14+ monocytes/macrophages.
- Type-1 and Type-2 cytokines were detected in approximately 20% of stimulated PBMC from healthy individuals, but showed reduced frequency in colorectal tumor patients.
Conclusions:
- The fermented mistletoe extract from pine trees demonstrates a favorable safety profile with significant immunomodulatory potential.
- The extract interacts with both specific (T helper cells) and non-specific (monocytes/macrophages) immune systems.
- Functional impairment of immunocompetent cells in colorectal tumor patients may be indicated by reduced cytokine responses.